Professional Media briefs

Slack is giving its Orthopedics Today website, OrthoSuperSite.com, a redesign. The site will feature a new look along with new formats for its news, journal reviews, videos, blogs, interactive commentary and reader feedback. The site, which incorporates Orthopedics Today Europe, Orthopedics, Athletic Training & Sports Healthcare and Orthopedics Hyperguide, boasts 81,431 monthly unique visitors and 213,967 monthly page views.

Lippincott Williams & Wilkins launched Female Pelvic Medicine & Reconstructive Surgery, the official journal of The American Urogynecologic Society. It's a retitling of LWW's Journal of Pelvic Medicine & Surgery, but it broadens the bimonthly's reach to cover the entire field of female pelvic medicine and reconstructive surgery, the society and the publisher said.

Gold Standard/Elsevier launched Clinical Pharmacology Mobile, a mobile device-optimized site offering users access to the features and functions of Clinical Pharmacology, an electronic drug information and medication management reference. The site lets users search by trade or generic name, indication, contraindication/precaution or adverse reaction, and to browse by monograph or classification.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.